HUP0103303A3 - Imidazole compounds, process for producing them, their use and medicaments containing them - Google Patents

Imidazole compounds, process for producing them, their use and medicaments containing them

Info

Publication number
HUP0103303A3
HUP0103303A3 HU0103303A HUP0103303A HUP0103303A3 HU P0103303 A3 HUP0103303 A3 HU P0103303A3 HU 0103303 A HU0103303 A HU 0103303A HU P0103303 A HUP0103303 A HU P0103303A HU P0103303 A3 HUP0103303 A3 HU P0103303A3
Authority
HU
Hungary
Prior art keywords
producing
imidazole compounds
medicaments containing
medicaments
imidazole
Prior art date
Application number
HU0103303A
Other languages
English (en)
Original Assignee
Astellas Pharma Inc Chuo Ku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP4840A external-priority patent/AUPP484098A0/en
Priority claimed from AUPP7355A external-priority patent/AUPP735598A0/en
Application filed by Astellas Pharma Inc Chuo Ku filed Critical Astellas Pharma Inc Chuo Ku
Publication of HUP0103303A2 publication Critical patent/HUP0103303A2/hu
Publication of HUP0103303A3 publication Critical patent/HUP0103303A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0103303A 1998-07-23 1999-07-22 Imidazole compounds, process for producing them, their use and medicaments containing them HUP0103303A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP4840A AUPP484098A0 (en) 1998-07-23 1998-07-23 Novel imidazole compounds
AUPP7355A AUPP735598A0 (en) 1998-11-27 1998-11-27 Novel imidazole compounds
PCT/JP1999/003939 WO2000005217A1 (en) 1998-07-23 1999-07-22 Imidazole compounds and their use as adenosine deaminase inhibitors

Publications (2)

Publication Number Publication Date
HUP0103303A2 HUP0103303A2 (hu) 2002-04-29
HUP0103303A3 true HUP0103303A3 (en) 2002-09-30

Family

ID=25645831

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103303A HUP0103303A3 (en) 1998-07-23 1999-07-22 Imidazole compounds, process for producing them, their use and medicaments containing them

Country Status (16)

Country Link
US (1) US6359145B1 (hu)
EP (1) EP1098885B9 (hu)
JP (1) JP4525883B2 (hu)
KR (1) KR100429754B1 (hu)
CN (1) CN1291979C (hu)
AT (1) ATE282599T1 (hu)
BR (1) BR9912684A (hu)
CA (1) CA2338305A1 (hu)
DE (1) DE69922009T2 (hu)
ES (1) ES2234269T3 (hu)
HK (1) HK1041264B (hu)
HU (1) HUP0103303A3 (hu)
MX (1) MXPA01000549A (hu)
PT (1) PT1098885E (hu)
RU (1) RU2243220C2 (hu)
WO (1) WO2000005217A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP921299A0 (en) 1999-03-15 1999-04-15 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
AUPR636301A0 (en) 2001-07-13 2001-08-02 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
AUPS058102A0 (en) * 2002-02-15 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
US20040175804A1 (en) * 2003-03-04 2004-09-09 Skonezny Paul M. Process for preparing dideoxyinosine using adenosine deaminase enzyme
TW200815388A (en) * 2006-04-18 2008-04-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
DE602007004018D1 (de) * 2006-05-23 2010-02-11 Meddev Inc Imidazolcarbonsäurealkylester-haltiges Medikament zur Behandlung neurodegenerativer Erkrankungen
US8314136B1 (en) 2006-05-23 2012-11-20 MedDEV, Inc. Method for treatment of alzheimer's disease and autism spectrum disorders
AU2008262664A1 (en) * 2007-06-11 2008-12-18 Valletta Health Ip Ee B.V. Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
JP5454458B2 (ja) * 2010-11-25 2014-03-26 信越化学工業株式会社 ポジ型レジスト材料及びパターン形成方法
CN108318594A (zh) * 2018-01-12 2018-07-24 上海中医药大学 一种液相色谱串联质谱法测定腺苷脱氨酶活性及筛选其抑制剂的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906965D0 (en) * 1989-03-28 1989-05-10 Schering Agrochemicals Ltd Fungicides
DE69401486T2 (de) * 1993-11-12 1997-04-30 Ishihara Sangyo Kaisha Verfahren zur Herstellung 2-cyanoimidazol Derivate
CA2261591A1 (en) * 1996-07-15 1998-01-22 Elie Abushanab Adenosine deaminase inhibitors

Also Published As

Publication number Publication date
HK1041264A1 (en) 2002-07-05
KR20010072037A (ko) 2001-07-31
HUP0103303A2 (hu) 2002-04-29
ATE282599T1 (de) 2004-12-15
JP2002521369A (ja) 2002-07-16
US6359145B1 (en) 2002-03-19
CA2338305A1 (en) 2000-02-03
EP1098885B9 (en) 2005-05-18
EP1098885A1 (en) 2001-05-16
BR9912684A (pt) 2001-05-02
KR100429754B1 (ko) 2004-05-03
EP1098885B1 (en) 2004-11-17
PT1098885E (pt) 2005-01-31
DE69922009D1 (de) 2004-12-23
JP4525883B2 (ja) 2010-08-18
CN1291979C (zh) 2006-12-27
RU2243220C2 (ru) 2004-12-27
HK1041264B (zh) 2007-08-17
CN1319095A (zh) 2001-10-24
MXPA01000549A (es) 2002-04-08
WO2000005217A1 (en) 2000-02-03
ES2234269T3 (es) 2005-06-16
DE69922009T2 (de) 2005-04-07

Similar Documents

Publication Publication Date Title
HUP0004422A3 (en) 2-aryl-8-oxohydropurine derivatives, process for producing them, medicaments containing the same
HU9904630D0 (en) New hydrazide compounds, process for their production and medicaments containing them
HUP0002050A3 (en) Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use
HUP9901820A3 (en) 4-amino pyrimidine derivatives, medicaments containing these compounds, their use and process for their production
HUP9702534A3 (en) Propiophenone derivatives, process for preparing them and medicaments containing the said compounds
IL140078A0 (en) Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
HUP0002842A3 (en) Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates
HUP9802259A3 (en) 1,4,5-substituted imidazole compounds, pharmaceutical compounds containing them, process for producing them and their use
IL146105A (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
HUP9900645A3 (en) Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing
HU9802224D0 (en) Pyrazol derivatives, process for producing them and their use as medicament
HUP0401081A3 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
HUP0102921A3 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
HUP0102210A3 (en) Substituted indolinones, the production thereof and their use for producing medicaments and medicaments containing same
HUP0100927A3 (en) Antitumor substituted indene-derivatives, process for their preparation, medicaments containing them and their use
HUP0104779A3 (en) Antihistaminic spiro compounds, process for their preparation and medicaments containing them
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0103303A3 (en) Imidazole compounds, process for producing them, their use and medicaments containing them
HUP9903902A3 (en) Bromotiacumicin compounds, process for producing them and medicaments containing the same
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
HUP9904628A3 (en) New imidazoline compounds, process for their production and medicaments containing them
HUP9903632A3 (en) Neuraminic acid compounds, medicaments containing the same and method for producing the same medicaments
HUP9702227A3 (en) New benzopirane compounds, process for producing them and pharmaceutical composition containing them
HUP9800472A3 (en) New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them
HUP9904592A3 (en) 1,2-dithiolane-derivatives, process for their production and medicaments containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ASTELLAS PHARMA INC., JP

Free format text: FORMER OWNER(S): FUJISAWA PHARMACEUTICAL CO., LTD., JP